131 related articles for article (PubMed ID: 16720380)
1. MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations.
Chen Y; Fan Y; Poon KY; Achrol AS; Lawton MT; Zhu Y; McCulloch CE; Hashimoto T; Lee C; Barbaro NM; Bollen AW; Yang GY; Young WL
Front Biosci; 2006 Sep; 11():3121-8. PubMed ID: 16720380
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations.
Hashimoto T; Wen G; Lawton MT; Boudreau NJ; Bollen AW; Yang GY; Barbaro NM; Higashida RT; Dowd CF; Halbach VV; Young WL;
Stroke; 2003 Apr; 34(4):925-31. PubMed ID: 12649522
[TBL] [Abstract][Full Text] [Related]
3. Plasma Matrix Metalloproeteinase-9 Is Associated with Seizure and Angioarchitecture Changes in Brain Arteriovenous Malformations.
Liu YT; Lee CC; Lin CF; Wu HM; Guo WY; Yang HC; Chang FC; Liou KD; Lin CJ
Mol Neurobiol; 2022 Oct; 59(10):5925-5934. PubMed ID: 35831556
[TBL] [Abstract][Full Text] [Related]
4. Evidence of inflammatory cell involvement in brain arteriovenous malformations.
Chen Y; Zhu W; Bollen AW; Lawton MT; Barbaro NM; Dowd CF; Hashimoto T; Yang GY; Young WL
Neurosurgery; 2008 Jun; 62(6):1340-9; discussion 1349-50. PubMed ID: 18825001
[TBL] [Abstract][Full Text] [Related]
5. Relevance of IL-6 and MMP-9 to cerebral arteriovenous malformation and hemorrhage.
Li X; Wang R; Wang X; Xue X; Ran D; Wang S
Mol Med Rep; 2013 Apr; 7(4):1261-6. PubMed ID: 23426918
[TBL] [Abstract][Full Text] [Related]
6. Vascular stability of brain arteriovenous malformations after partial embolization.
He Y; He Y; Bai W; Guo D; Lu T; Duan L; Li Z; Kong L; Hernesniemi JA; Li T
CNS Neurosci Ther; 2024 Mar; 30(3):e14136. PubMed ID: 36852445
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of angiogenic factors in brain arteriovenous malformations.
Hashimoto T; Wu Y; Lawton MT; Yang GY; Barbaro NM; Young WL
Neurosurgery; 2005 May; 56(5):1058-65; discussion 1058-65. PubMed ID: 15854255
[TBL] [Abstract][Full Text] [Related]
8. Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 2 Expression in Brain Arteriovenous Malformations and its Association with Brain Arteriovenous Malformation Size.
Neyazi B; Tanrikulu L; Wilkens L; Hartmann C; Stein KP; Dumitru CA; Sandalcioglu IE
World Neurosurg; 2017 Jun; 102():79-84. PubMed ID: 28279775
[TBL] [Abstract][Full Text] [Related]
9. Brain arteriovenous malformations: implications of CEACAM1-positive inflammatory cells and sex on hemorrhage.
Neyazi B; Herz A; Stein KP; Gawish I; Hartmann C; Wilkens L; Erguen S; Dumitru CA; Sandalcioglu IE
Neurosurg Rev; 2017 Jan; 40(1):129-134. PubMed ID: 27215911
[TBL] [Abstract][Full Text] [Related]
10. Expression of osteopontin, matrix metalloproteinase-2 and -9 proteins in vascular instability in brain arteriovenous malformation.
Anbarasen L; Lim J; Rajandram R; Mun KS; Sia SF
PeerJ; 2019; 7():e7058. PubMed ID: 31275742
[TBL] [Abstract][Full Text] [Related]
11. The relationship between maximal exercise-induced increases in serum IL-6, MPO and MMP-9 concentrations.
Reihmane D; Jurka A; Tretjakovs P
Scand J Immunol; 2012 Aug; 76(2):188-92. PubMed ID: 22594650
[TBL] [Abstract][Full Text] [Related]
12. Systemic expression of matrix metalloproteinase-9 in patients with cerebral arteriovenous malformations.
Starke RM; Komotar RJ; Hwang BY; Hahn DK; Otten ML; Hickman ZL; Garrett MC; Sisti MB; Lavine SD; Meyers PM; Solomon RA; Connolly ES
Neurosurgery; 2010 Feb; 66(2):343-8; discussion 348. PubMed ID: 20087134
[TBL] [Abstract][Full Text] [Related]
13. Suppression of MMP-9 by doxycycline in brain arteriovenous malformations.
Hashimoto T; Matsumoto MM; Li JF; Lawton MT; Young WL;
BMC Neurol; 2005 Jan; 5(1):1. PubMed ID: 15667660
[TBL] [Abstract][Full Text] [Related]
14. Salivary Matrix Metalloproteinase-8 and -9 and Myeloperoxidase in Relation to Coronary Heart and Periodontal Diseases: A Subgroup Report from the PAROKRANK Study (Periodontitis and Its Relation to Coronary Artery Disease).
Rathnayake N; Gustafsson A; Norhammar A; Kjellström B; Klinge B; Rydén L; Tervahartiala T; Sorsa T;
PLoS One; 2015; 10(7):e0126370. PubMed ID: 26132583
[TBL] [Abstract][Full Text] [Related]
15. Nidal embolization of brain arteriovenous malformations: rates of cure, partial embolization, and clinical outcome.
Sahlein DH; Mora P; Becske T; Nelson PK
J Neurosurg; 2012 Jul; 117(1):65-77. PubMed ID: 22540403
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses.
Marzano AV; Cugno M; Trevisan V; Lazzari R; Fanoni D; Berti E; Crosti C
Int J Immunopathol Pharmacol; 2011; 24(2):451-60. PubMed ID: 21658319
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Expression of Angioarchitecture-related Factors in Patients with Cerebral Arteriovenous Malformation.
Chen GZ; Ke Y; Qin K; Dong MQ; Zeng SJ; Lin XF; Zhan SQ; Tang K; Peng C; Ding XW; Zhou D
Chin Med J (Engl); 2017 Oct; 130(20):2465-2472. PubMed ID: 29052569
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent changes of collagen alpha-2(IV) expression in the extracellular matrix of brain arteriovenous malformations.
Neyazi B; Stein KP; Wilkens L; Maslehaty H; Dumitru CA; Sandalcioglu IE
Clin Neurol Neurosurg; 2020 Feb; 189():105589. PubMed ID: 31837516
[TBL] [Abstract][Full Text] [Related]
19. [The analysis of selected biochemical parameters concentration in pregnant women with idiopathic edema of the lower limbs--preliminary report].
Sikora-Szubert A; Kowalska-Koprek U; Karowicz-Bilińska A
Ginekol Pol; 2012 Sep; 83(9):660-4. PubMed ID: 23342893
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model.
Zhu W; Chen W; Zou D; Wang L; Bao C; Zhan L; Saw D; Wang S; Winkler E; Li Z; Zhang M; Shen F; Shaligram S; Lawton M; Su H
Stroke; 2018 May; 49(5):1232-1240. PubMed ID: 29593101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
